Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99
- Resource Type
- Article
- Authors
- Pagani, O. ; Klingbiel, D.; Ruhstaller, T.; Nolè, F.; Eppenberger, S.; Oehlschlegel, C.; Bernhard, J.; Brauchli, P.; Hess, D.; Mamot, C.; Munzone, E.; Pestalozzi, B.; Rabaglio, M.; Aebi, S.; Ribi, K.; Rochlitz, C.; Rothgiesser, K.; Thürlimann, B.; von Moos, R.; Zaman, K.; Goldhirsch, A.
- Source
- In Annals of Oncology February 2017 28(2):305-312
- Subject
- Language
- ISSN
- 0923-7534